SG11201604786QA - Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof - Google Patents
Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereofInfo
- Publication number
- SG11201604786QA SG11201604786QA SG11201604786QA SG11201604786QA SG11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA SG 11201604786Q A SG11201604786Q A SG 11201604786QA
- Authority
- SG
- Singapore
- Prior art keywords
- cortisol
- polymorphic
- benzoate
- alpha
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361915589P | 2013-12-13 | 2013-12-13 | |
PCT/US2014/070147 WO2015089471A2 (en) | 2013-12-13 | 2014-12-12 | Polymorphic forms of a steroid-like compound and methods for the preparation and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201604786QA true SG11201604786QA (en) | 2016-07-28 |
Family
ID=52293229
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201604786QA SG11201604786QA (en) | 2013-12-13 | 2014-12-12 | Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof |
SG10201709987QA SG10201709987QA (en) | 2013-12-13 | 2014-12-12 | Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201709987QA SG10201709987QA (en) | 2013-12-13 | 2014-12-12 | Polymorphic and amorphous forms of cortisol 17-alpha-benzoate and methods for the preparation and use thereof |
Country Status (17)
Country | Link |
---|---|
US (1) | US10065984B2 (es) |
EP (1) | EP3080140A2 (es) |
JP (1) | JP2016540001A (es) |
KR (1) | KR20160098338A (es) |
CN (1) | CN105814071A (es) |
AR (1) | AR098747A1 (es) |
AU (1) | AU2014361790B2 (es) |
CA (1) | CA2933371A1 (es) |
CL (1) | CL2016001429A1 (es) |
IL (1) | IL246059A0 (es) |
MX (1) | MX371012B (es) |
PH (1) | PH12016501098A1 (es) |
SA (1) | SA516371308B1 (es) |
SG (2) | SG11201604786QA (es) |
TW (1) | TWI659041B (es) |
UA (1) | UA121203C2 (es) |
WO (1) | WO2015089471A2 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019055028A1 (en) * | 2017-09-15 | 2019-03-21 | Kala Pharmaceuticals, Inc. | PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC APPLICATIONS AND / OR OTHER APPLICATIONS |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL6605514A (es) * | 1966-04-25 | 1967-10-26 | ||
IT1056711B (it) * | 1967-04-01 | 1982-02-20 | Vismara F Spa | Derivati dell idrocortisone |
JPS52136157A (en) | 1976-04-14 | 1977-11-14 | Taisho Pharmaceut Co Ltd | Preparation of steroid 17-esters |
JPS54151958A (en) * | 1978-05-19 | 1979-11-29 | Taisho Pharmaceut Co Ltd | Preparation of pregnane steroid 17alpha-ester |
US8501800B2 (en) * | 2009-03-05 | 2013-08-06 | Insite Vision Incorporated | Controlled-release ophthalmic vehicles |
EP2619205B1 (en) * | 2010-09-23 | 2017-05-17 | AbbVie Bahamas Ltd. | Monohydrate of an azaadamantane derivative |
UA111867C2 (uk) * | 2011-11-11 | 2016-06-24 | Аллерган, Інк. | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ І СПОСІБ ЗАСТОСУВАННЯ ПОХІДНИХ 4-ПРЕГНЕН-11β-17-21-ТРІОЛ-3,20-ДІОНУ |
CA2873214C (en) * | 2012-05-11 | 2021-02-16 | Reset Therapeutics, Inc. | Carbazole-containing sulfonamides as cryptochrome modulators |
-
2014
- 2014-12-12 AR ARP140104647A patent/AR098747A1/es unknown
- 2014-12-12 EP EP14824667.1A patent/EP3080140A2/en not_active Ceased
- 2014-12-12 AU AU2014361790A patent/AU2014361790B2/en not_active Ceased
- 2014-12-12 CA CA2933371A patent/CA2933371A1/en not_active Abandoned
- 2014-12-12 MX MX2016007718A patent/MX371012B/es active IP Right Grant
- 2014-12-12 CN CN201480067887.4A patent/CN105814071A/zh active Pending
- 2014-12-12 TW TW103143530A patent/TWI659041B/zh not_active IP Right Cessation
- 2014-12-12 US US14/568,450 patent/US10065984B2/en not_active Expired - Fee Related
- 2014-12-12 SG SG11201604786QA patent/SG11201604786QA/en unknown
- 2014-12-12 KR KR1020167018491A patent/KR20160098338A/ko not_active Application Discontinuation
- 2014-12-12 JP JP2016538591A patent/JP2016540001A/ja active Pending
- 2014-12-12 UA UAA201606521A patent/UA121203C2/uk unknown
- 2014-12-12 SG SG10201709987QA patent/SG10201709987QA/en unknown
- 2014-12-12 WO PCT/US2014/070147 patent/WO2015089471A2/en active Application Filing
-
2016
- 2016-06-06 IL IL246059A patent/IL246059A0/en unknown
- 2016-06-09 PH PH12016501098A patent/PH12016501098A1/en unknown
- 2016-06-10 CL CL2016001429A patent/CL2016001429A1/es unknown
- 2016-06-13 SA SA516371308A patent/SA516371308B1/ar unknown
Also Published As
Publication number | Publication date |
---|---|
SA516371308B1 (ar) | 2019-07-08 |
MX2016007718A (es) | 2016-09-09 |
WO2015089471A3 (en) | 2015-11-19 |
KR20160098338A (ko) | 2016-08-18 |
CA2933371A1 (en) | 2015-06-18 |
TWI659041B (zh) | 2019-05-11 |
MX371012B (es) | 2020-01-10 |
EP3080140A2 (en) | 2016-10-19 |
CN105814071A (zh) | 2016-07-27 |
AU2014361790A1 (en) | 2016-07-07 |
AU2014361790B2 (en) | 2019-05-23 |
AR098747A1 (es) | 2016-06-08 |
US10065984B2 (en) | 2018-09-04 |
SG10201709987QA (en) | 2018-01-30 |
TW201609788A (zh) | 2016-03-16 |
CL2016001429A1 (es) | 2016-12-23 |
UA121203C2 (uk) | 2020-04-27 |
JP2016540001A (ja) | 2016-12-22 |
IL246059A0 (en) | 2016-07-31 |
PH12016501098A1 (en) | 2016-08-15 |
WO2015089471A2 (en) | 2015-06-18 |
US20150166597A1 (en) | 2015-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280155A (en) | Anti- SIGLEC-8 antibodies and methods of using them | |
IL290547A (en) | Antibodies and methods of use | |
IL244495B (en) | Anti-alpha-synuclein antibodies and methods of use | |
GB2535360B (en) | Methods of preparing polyhemiaminals and polyhexahydrotriazines | |
HRP20170840T4 (hr) | Supstituirani ksantini i metode njihove uporabe | |
HK1217708A1 (zh) | 新的雷公藤甲素衍生物及其製備方法和用途 | |
HK1225612A1 (zh) | 抗ly6e抗體及使用方法 | |
HK1218388A1 (zh) | 奧那司酮多晶型形式和使用方法 | |
IL246059A0 (en) | Polymorphic and amphoteric forms of cortisol 17-alpha-benzoate and methods for their preparation and use |